Hence, hyperinsulinemia and elevated bioavailable IGF-1 levels support a carcinogenic and early tumor growth setting in some cancers, such as in the case of CRC, where this association has been determined, independent of adiposity [35], [40], [41]. This evidence concerns the gene IGF1 and cancer.